![]() Lixte Biotechnology Lixte Biotechnology Holdings is a drug discovery company that uses biomarker technology to identify enzyme targets associated with serious common diseases and then designs novel compounds to attack those targets. | ![]() Scynexis Scynexis is engaged in drug discovery, development and manufacturing projects in various areas. | ![]() NGM Biopharmaceuticals NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system. | ![]() Chiesi Group Chiesi Group (Gruppo Chiesi, also known as CHIESI Farmaceutici) is a company that researches, develops, produces, and commercializes therapeutic solutions. | ||
Founding Date | Founding Date 2006 | Founding Date 2000 | Founding Date 2007 | Founding Date 1904 | Founding Date 1935 |
Type | Type Public | Type Public | Type Public | Type Subsidiary | Type Subsidiary |
Tags | |||||
Locations | Locations East Setauket, US HQ Pasadena, US | Locations Jersey City, US HQ | Locations South San Francisco, US HQ | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more | Locations Parma, IT HQ Melbourne, AU Wien, AT Machelen, BE Santana De Parnaíba, BR São Paulo, BR Sofia, BG see more |
Employees | Employees 3 | Employees 3636% decrease | Employees 18622% increase | Employees 7,5692% decrease | Employees 5,8541% increase |
Valuation ($) | Valuation ($) 2.9 m | Valuation ($) 53 m | Valuation ($) 128.5 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $20.6m (FY, 2025) | Revenue (est.) $4.4m (FY, 2023) | Revenue (est.) $7.9b (FY, 2020) | Revenue (est.) €2.4b (Y, 2021) |
Net income | Net income ($6m) (FY, 2025) | Net income ($8.6m) (FY, 2025) | Net income ($142.4m) (FY, 2023) | Net income N/A | Net income N/A |
Operating ⚠ | |||||
Patents | Patents 51 (FY, 2019) | Patents N/A | Patents N/A | Patents 1 (Dec, 2020) | Patents N/A |
Funding | |||||
Total funding raised | Total funding raised $ 1.8m | Total funding raised $ 11.5m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A |

Scynexis is engaged in drug discovery, development and manufacturing projects in various areas.
View company
NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.
View company
Chiesi Group (Gruppo Chiesi, also known as CHIESI Farmaceutici) is a company that researches, develops, produces, and commercializes therapeutic solutions.
View company